Schneider L S, Cooper T B, Suckow R F, Lyness S A, Haugen C, Palmer R, Sloane R B
Department of Psychiatry, University of Southern California School of Medicine, Los Angeles.
J Clin Psychopharmacol. 1990 Oct;10(5):333-7.
Plasma concentration of E-10-hydroxynortriptyline is increased in the elderly and may be related to both renal clearance of hydroxynortriptyline and rate of liver hydroxylation of nortriptyline. In 25 ambulatory, depressed elderly outpatients treated with therapeutic doses of nortriptyline, relationships among plasma levels of nortriptyline and E-10-hydroxynortriptyline, and an estimate of creatinine clearance were examined. Plasma levels of E-10-hydroxynortriptyline (corrected for varying dosage) were significantly correlated with age and inversely correlated (r = -0.50) with creatinine clearance but not with notriptyline or Z-10-hydroxynortriptyline concentration. E-10-hydroxynortriptyline concentration was about 5 1/2 times that of Z-10-hydroxynortriptyline. By best subsets multiple regression analyses, the ratio of E-10-hydroxynortriptyline to nortriptyline level was best predicted by plasma nortriptyline concentration, creatinine clearance, and age, all of which accounted for 63% of the variance. These results corroborate and extend previous findings in elderly inpatients in whom creatinine clearance was measured directly. In addition, age had an effect on E-10-hydroxynortriptyline independently of creatinine clearance. Since E-10-hydroxynortriptyline concentration has been related to both therapeutic efficacy and toxicity during nortriptyline treatment, it may be important to assess nortriptyline hydroxymetabolites in elderly patients and in those with renal insufficiency.
10-羟基去甲替林的血浆浓度在老年人中升高,可能与羟基去甲替林的肾脏清除率以及去甲替林的肝脏羟化速率均有关。在25名接受治疗剂量去甲替林治疗的门诊抑郁老年患者中,研究了去甲替林和10-羟基去甲替林的血浆水平之间的关系以及肌酐清除率的估计值。10-羟基去甲替林的血浆水平(校正不同剂量后)与年龄显著相关,与肌酐清除率呈负相关(r = -0.50),但与去甲替林或10-羟基去甲替林的Z异构体浓度无关。10-羟基去甲替林的浓度约为10-羟基去甲替林Z异构体浓度的5.5倍。通过最佳子集多元回归分析,血浆去甲替林浓度、肌酐清除率和年龄对10-羟基去甲替林与去甲替林水平的比值预测效果最佳,所有这些因素占变异的63%。这些结果证实并扩展了先前对直接测量肌酐清除率的老年住院患者的研究结果。此外,年龄对10-羟基去甲替林有独立于肌酐清除率的影响。由于10-羟基去甲替林浓度与去甲替林治疗期间的治疗效果和毒性均有关,因此评估老年患者和肾功能不全患者的去甲替林羟基代谢产物可能很重要。